Mind Medicine (MindMed) (MMEDF) Stock Price, News & Analysis

Company Overview

Mind Medicine (MindMed) is a clinical-stage biopharmaceutical company focused on developing therapies for brain health and psychiatric disorders. The company researches medicines derived from or inspired by psychedelic and empathogenic compounds, with the goal of addressing conditions that may not respond adequately to existing treatments.

MindMed’s lead program, MM120, is an orally administered formulation of lysergide, commonly known as LSD, being evaluated for anxiety and other psychiatric disorders. The company has also advanced MM402, an investigational therapy based on the R-enantiomer of MDMA, for potential use in neuropsychiatric conditions including autism spectrum disorder. Its programs are subject to clinical testing and regulatory review.

Founded in 2019, MindMed conducts research and clinical development activities in the United States and works with academic, medical and research partners. Robert Barrow serves as the company’s chief executive officer and has been associated with its efforts to advance psychedelic-inspired medicines through clinical development.

Key Stats

• Today's Range: $32.84 to $34.88
• 50-Day Range: $34.18 to $46.18
• 52-Week Range: $0.29 to $5.07
• Volume: 2.10 million shs
• Average Volume: 3.38 million shs
• Market Capitalization: N/A
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: N/A

Industry, Sector and Symbol

• Stock Exchange: OTCMKTS
• Sector: Healthcare
• Industry: Pharmaceuticals
• Sub-Industry: Pharmaceuticals
• Current Symbol: OTCMKTS:MMEDF
• CIK: N/A
• Web: www.mindmed.co
• Phone: (212) 220-6633
• Fax: N/A
• Employees: 40
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): N/A
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: N/A
• Net Margins: N/A
• Pretax Margin: N/A
• Return on Equity: N/A
• Return on Assets: N/A

Debt

• Debt-to-Equity Ratio: N/A
• Current Ratio: N/A
• Quick Ratio: N/A

Sales & Book Value

• Annual Sales: N/A
• Price / Sales: N/A
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: N/A
• Price / Book: N/A

Miscellaneous

• Outstanding Shares: N/A
• Free Float: N/A
• Market Cap: N/A
• Optionable: Not Optionable
• Beta: N/A